本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

IO Biotech, Inc.

1.89
+0.190011.18%
盤後1.980.0884+4.68%19:52 EDT
成交量:43.59萬
成交額:75.81萬
市值:1.25億
市盈率:-1.26
高:1.89
開:1.77
低:1.65
收:1.70
資料載入中...
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/09

SEC問詢函

Form CORRESP - Correspondence
2024/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/26

重要事件披露

Form 8-K - Current report
2024/03/22

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities